References
Funder JW, Carey RM, Mantero F, Murad MH, Reincke M, Shibata H, Stowasser M, Young WF Jr (2016) The management of primary aldosteronism: Case detection, diagnosis, and treatment: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 101:1889–1916. https://doi.org/10.1210/jc.2015-4061
Bioletto F, Bollati M, Lopez C, Arata S, Procopio M, Ponzetto F, Ghigo E, Maccario M, Parasiliti-Caprino M (2022) Primary aldosteronism and resistant hypertension: a pathophysiological insight. Int J Mol Sci 23:4803. https://doi.org/10.3390/ijms23094803
Mulatero P, Bertello C, Veglio F, Monticone S (2022) Approach to the patient on antihypertensive therapy: screen for primary aldosteronism. J Clin Endocrinol Metab. https://doi.org/10.1210/clinem/dgac460
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors report no conflicts of interest in this work.
Research involving human participants and/or animals
Not applicable.
Informed consent
Not applicable.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Parasiliti-Caprino, M., Ghigo, E. & Maccario, M. Primary aldosteronism is a clinical issue that should not be underestimated anymore. J Endocrinol Invest 46, 639–640 (2023). https://doi.org/10.1007/s40618-022-01981-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40618-022-01981-6